-
Innovation Ranking
NewInnovation Ranking – H&R Block Inc
H&R Block Inc (H&R Block) is a provider of consumer tax services worldwide. It offers tax return preparation services through professional tax preparers in company-owned and franchise retail tax offices; and provide H&R Block tax software products for the Do-It-Yourself (DIY) consumer. It Offers DIY products through channels such as in-person, online and mobile applications, and desktop software. It also offers services such as refund transfers, emerald advance line of credit, emerald prepaid MasterCard, extended service plan, tax identity shield,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – R-835 in Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-835 in Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-835 in Lupus Erythematosus Drug Details: R-835 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – R-327 in Bacterial Sepsis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-327 in Bacterial Sepsis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-327 in Bacterial Sepsis Drug Details: R-327 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – R-835 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-835 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-835 in Rheumatoid Arthritis Drug Details: R-835 is under development for the...
-
Product Insights
R Power Poland Solar PV Project, Poland
R Power Poland Solar PV Project is proposed to be developed in Poland. Empower your strategies with our R Power Poland Solar PV Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-327 in Influenza A Virus, H1N1 Subtype Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-327 in Influenza A Virus, H1N1 Subtype Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-327 in Influenza A Virus, H1N1 Subtype...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-2R01 in Acute Renal Failure (ARF) (Acute Kidney Injury)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-2R01 in Acute Renal Failure (ARF) (Acute Kidney Injury) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-2R01 in Acute Renal Failure (ARF) (Acute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-289 in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-289 in Inflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-289 in Inflammation Drug Details: R-289 is under development for myelodysplastic syndrome and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Gastric Cancer Drug Details: iNeo-Vac-R01 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – R-01 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - R-01 in Metastatic Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. R-01 in Metastatic Pancreatic Cancer Drug Details: iNeo-Vac-R01 is under development...